Chao Lv

Chao Lv

Auto-generated profile, based on publicly available information

Chao Lv

Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2024 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
XCXiangyuan Chu
Xiangyuan Chu
YTYu Tian
Yu Tian
CLChao Lv
Chao Lv
Tumor-associated macrophages (TAMs) are pivotal in cancer progression, influencing tumor growth, angiogenesis, and immune evasion. This review explores the spatial and temporal heterogeneity of TAMs within the tumor microenvironment (TME), highlighting their diverse subtypes, origins, and functions. Advanced technologies such as single-cell sequencing and spatial multi-omics have elucidated the intricate interactions between TAMs and other TME components, revealing the mechanisms behind their recruitment, polarization, and distribution. Key findings demonstrate that TAMs support tumor vascularization, promote epithelial-mesenchymal transition (EMT), and modulate extracellular matrix (ECM) remodeling, etc., thereby enhancing tumor invasiveness and metastasis. Understanding these complex dynamics offers new therapeutic targets for disrupting TAM-mediated pathways and overcoming drug resistance. This review underscores the potential of targeting TAMs to develop innovative cancer therapies, emphasizing the need for further research into their spatial characteristics and functional roles within the TME.

26 April 2025 in Cell Biology and Toxicology
Verified
Journal Article
Open access
PDF file
CMChuhan Ma
Chuhan Ma
HHHuixin Hu
Huixin Hu
HLHao Liu
Hao Liu
CZChongli Zhong
Chongli Zhong
BWBaokang Wu
Baokang Wu
YTYu Tian
Yu Tian
The vulnerability of tumor cells to lipid peroxidation, driven by redox imbalance and lipid overabundance within the tumor microenvironment (TME), has become a focal point for novel antitumor strategies. Ferroptosis, a form of regulated cell death predicated on lipid peroxidation, is emerging as a promising approach. Beyond their role in directly eliminating tumor cells, lipid peroxidation and its products, such as 4-hydroxynonenal (HNE), exert an additional influence by damaging DNA and shaping an environment conducive to tumor growth and metastasis. This process polarizes macrophages towards a pro-inflammatory phenotype, dampens the antigen-presenting capacity of dendritic cells (DCs), and undermines the cytotoxic functions of T and NK cells. Furthermore, it transforms neutrophils into pro-tumorigenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). The lipid peroxidation of stroma cells also contributes to tumor progression. Although advanced nanotherapies have shown the ability to target tumor cells precisely, they often overlook the nuanced effects of lipid peroxidation products. In this review, we highlight a synergistic mechanism in which lipid peroxidation products and ferroptosis contribute to an immunosuppressive state that is temporally distinct from cell death. This insight broadens our understanding of ferroptosis-derived immunosuppression, encompassing all types of immune cells within the TME. This review aims to catalyze further research in this underexplored area, emphasizing the potential of lipid peroxidation products to hinder the clinical translation of ferroptosis-based therapies. Graphical abstract

26 January 2026 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
XCXiangyuan Chu
Xiangyuan Chu
JMJunying Ma
Junying Ma
SLShihua Li
Shihua Li
MWMeng Wang
Meng Wang
YTYu Tian
Yu Tian
CLChao Lv
Chao Lv
Neutrophils, traditionally regarded as short-lived first responders of innate immunity, have emerged as pivotal regulators within the tumor microenvironment (TME). Recent advances reveal that tumor-associated neutrophils (TANs) and neutrophil extracellular traps (NETs) exhibit remarkable spatiotemporal heterogeneity, with their phenotypes and functions dynamically evolving across tumor developmental stages and anatomical niches. TANs and NETs display dual and context-dependent roles: they can promote tumor progression via immune suppression, angiogenesis, extracellular matrix remodeling, and metastatic niche formation, yet also exert anti-tumor functions through cytotoxicity and antigen presentation under specific microenvironmental cues. This review systematically dissects the spatial and temporal dynamics of TANs and NETs, emphasizing their molecular regulation by tumor-derived secretomes, chemokine gradients, hypoxia, stromal interactions, and inflammatory signaling networks. We further delineate the bidirectional crosstalk between TANs and other immune or stromal components that contributes to immune evasion and therapy resistance. Beyond mechanistic insights, we highlight emerging therapeutic strategies, ranging from chemokine axis blockade and phenotypic reprogramming to NETs inhibition and clearance, that hold promise for disrupting neutrophil-mediated tumor support. Finally, we advocate for the integration of cutting-edge spatial and single-cell multi-omics, imaging cytometry, and AI-assisted spatial modeling to enable high-resolution mapping of neutrophil dynamics in situ and to guide precision immunotherapy.

3 January 2025 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Open access
PDF file
CMChuhan Ma
Chuhan Ma
YLYang Li
Yang Li
MLMin Li
Min Li
CLChao Lv
Chao Lv
YTYu Tian
Yu Tian
Myeloid cells accumulate extensively in most tumors and play a critical role in immunosuppression of the tumor microenvironment (TME). Like T cells, myeloid cells also express immune checkpoint molecules, which induce the immunosuppressive phenotype of these cells. In this review, we summarize the tumor-promoting function and immune checkpoint expression of four types of myeloid cells: macrophages, neutrophils, dendritic cells, and myeloid-derived suppressor cells, which are the main components of the TME. By summarizing the research status of myeloid checkpoints, we propose that blocking immune checkpoints on myeloid cells might be an effective strategy to reverse the immunosuppressive status of the TME. Moreover, combining nanotechnology, cellular therapy, and bispecific antibodies to achieve precise targeting of myeloid immune checkpoints can help to avoid the adverse effects of systemic administration, ultimately achieving a balance between efficacy and safety in cancer therapy. Graphical abstract

18 July 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
CMChuhan Ma
Chuhan Ma
HHHuixin Hu
Huixin Hu
HLHanrong Li
Hanrong Li
BHBing Han
Bing Han
CLChao Lv
Chao Lv
YTYu Tian
Yu Tian
Introduction: Gallbladder cancer (GBC) is a highly lethal cancer with a poor prognosis. The adenoma-carcinoma sequence is a recognized model for GBC development, but its underlying mechanisms are not well understood. Methods: Human specimens were collected from Shengjing Hospital of China Medical University. Single-cell isolation and sequencing were conducted on cells from four GBC and four gallbladder adenomatous lesions (GBA) samples, and the raw gene expression matrices were analyzed using R software with the Seurat package. This included cell type annotation, differential gene expression analysis, functional enrichment, and gene set score calculation. Additional analyses such as protein-protein interaction network, immune infiltrate analysis, high-dimensional weighted gene co-expression network analysis, and cell-cell communication analysis were also performed. Results: The study revealed that epithelial-mesenchymal transition (EMT) plays a key role in the malignant transformation of epithelial cells from GBA to GBC. The immune landscape of GBC is predominantly immunosuppressive compared to the inflammatory environment within GBA. A specific subset of fibroblasts with extracellular matrix remodeling capabilities appears to be a major driver of the TME differences between GBC and GBA, potentially acting through COL1A2-mediated cell communication. Discussion: This work highlights the distinct roles of various cell types in the TME of GBA and GBC, and emphasizes the importance of understanding the mechanisms of malignant transformation from adenomatous lesion to carcinoma in the gallbladder. The findings pave the way for further research into the mechanisms underlying the adenoma-carcinoma sequence.

8 December 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
ZCZhanhao Chang
Zhanhao Chang
CZChongli Zhong
Chongli Zhong
SXShuo Xu
Shuo Xu
YZYuyang Zhang
Yuyang Zhang
XGXingqi Guo
Xingqi Guo
YTYu Tian
Yu Tian
Colon adenocarcinoma (COAD) has a limited response to immunotherapy due to its immunologically “cold” tumor microenvironment (TME). Efferocytos